MARRAS, FRANCESCO
 Distribuzione geografica
Continente #
EU - Europa 1.984
AS - Asia 195
NA - Nord America 72
SA - Sud America 17
AF - Africa 5
Totale 2.273
Nazione #
IT - Italia 1.953
SG - Singapore 95
US - Stati Uniti d'America 65
VN - Vietnam 45
CN - Cina 41
FR - Francia 17
BR - Brasile 10
HK - Hong Kong 8
AR - Argentina 5
DE - Germania 5
CA - Canada 3
MX - Messico 3
ZA - Sudafrica 3
IE - Irlanda 2
IN - India 2
BD - Bangladesh 1
CH - Svizzera 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
ES - Italia 1
FI - Finlandia 1
GB - Regno Unito 1
HR - Croazia 1
LT - Lituania 1
PH - Filippine 1
PK - Pakistan 1
SI - Slovenia 1
SN - Senegal 1
TN - Tunisia 1
UZ - Uzbekistan 1
VE - Venezuela 1
Totale 2.273
Città #
Genova 1.050
Genoa 512
Rapallo 235
Vado Ligure 150
Singapore 50
San Jose 24
Ho Chi Minh City 17
Lauterbourg 15
Beijing 11
Hong Kong 8
Hanoi 6
Frankfurt am Main 5
New York 5
Council Bluffs 4
Ashburn 3
Buenos Aires 3
Montreal 3
Santa Clara 3
Atlanta 2
Dublin 2
Johannesburg 2
Mexico City 2
Phú Thọ 2
Bacoli 1
Barquisimeto 1
Betim 1
Biên Hòa 1
Bordighera 1
Brooklyn 1
Bắc Ninh 1
Campo Grande 1
Cape Town 1
Cardeal da Silva 1
Catalão 1
City of London 1
Corbeil-Essonnes 1
Da Nang 1
Dakar 1
Davao City 1
Denver 1
El Bosque 1
Elk Grove Village 1
Formosa 1
Ha Long 1
Helsinki 1
Holly Springs 1
Indianapolis 1
Ipirá 1
Joinville 1
Karachi 1
Ljubljana 1
Los Angeles 1
Madrid 1
Marseille 1
Miami 1
Mumbai 1
Newberry 1
Nha Trang 1
Norwalk 1
Orem 1
Padua 1
Phủ Lý 1
Presidente Prudente 1
Quảng Nam Province 1
Quảng Ngãi 1
Rio de Janeiro 1
Rio do Sul 1
Rockingham 1
Rosario 1
Salvador 1
Samarkand 1
Santo Domingo 1
Seattle 1
Tianjin 1
Tremestieri Etneo 1
Zagreb 1
Zurich 1
Totale 2.168
Nome #
Use of maraviroc in clinical practice: a multicenter observational study 187
Activating NK cell receptor expression/function (NKp30, NKp46, DNAM-1) during chronic viraemic HCV infection is associated with the outcome of combined treatment. 177
Natural killer cells in HIV controller patients express an activated effector phenotype and do not up-regulate NKp44 on IL-2 stimulation. 176
Analysis of NK cell function and receptor expression during HTLV-1 and HTLV-2 infection 167
Relationship between innate immunity, soluble markers and metabolic-clinical parameters in HIV+ patients ART treated with HIV-RNA < 50 cp/mL 167
Popolazione di precursori linfoidi umani, metodo per la loro identificazione e relativi usi 163
Successfully treated HIV-infected patients have differential expression of NK cell receptors (NKp46 and NKp30) according to AIDS status at presentation. 159
NK-cell phenotype at interruption underlies widely divergent duration of CD4+-guided antiretroviral treatment interruption. 146
Control of the HIV-1 DNA reservoir is associated in vivo and in vitro with NKp46/NKp30 (CD335 CD337) inducibility and interferon gamma production by transcriptionally unique NK cells 144
Receptor modulation and functional activation of human CD34(+) Lin(-) -derived immature NK-cells in vitro by Mycobacterium Bovis Calmette-Guerin (BCG). 143
Natural killer cell development and maturation revisited: Possible implications of a novel distinct Lin-CD34+DNAM-1brightCXCR4+ cell progenitor 135
Valutazione di parametri di immunità innata e di infiammazione correlati ad aspetti clinico-metabolici in una coorte di pazienti HIV positivi con carica virale non rilevabile 121
Activating Killer Immunoglobulin Receptors and HLA-C: A successful combination providing HIV-1 control 120
METODO PER L'ANALISI CINETICA DI PRODUZIONE DI CITOCHINE E/O CHEMOCHINE DA PARTE DI SINGOLI SUBSET DI CELLULE NATURAL KILLER UMANE 109
Immunological profile of an infant treated with integrase inhibitor from the neonatal period 97
Method for the identification of the microparticles relased by natural-killer cells and uses thereof. 80
Totale 2.291
Categoria #
all - tutte 7.553
article - articoli 5.402
book - libri 0
conference - conferenze 514
curatela - curatele 0
other - altro 0
patent - brevetti 1.150
selected - selezionate 0
volume - volumi 487
Totale 15.106


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202122 0 0 0 0 0 0 0 0 0 12 7 3
2021/2022234 13 17 20 23 9 14 8 56 16 18 10 30
2022/2023284 24 37 2 33 29 47 3 24 33 9 37 6
2023/2024119 6 17 4 21 8 12 5 3 8 8 11 16
2024/2025354 18 20 19 28 46 36 34 70 2 15 32 34
2025/2026466 93 11 17 36 103 29 74 15 39 49 0 0
Totale 2.291